Item 16. Form 10-K Summary
4K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Signature | PERKINELMER, INC. Title | Date | |||
| By: | /S/ PRAHLAD SINGH, PhD | President and Chief Executive Officer | February 25, 2020 | ||
| Prahlad Singh, PhD | (Principal Executive Officer) | ||||
| By: | /S/ JAMES M. MOCK | Sr. Vice President and | February 25, 2020 | ||
| James M. Mock | Chief Financial Officer (Principal Financial Officer) | ||||
| By: | /S/ ANDREW OKUN | Vice President and | February 25, 2020 | ||
| Andrew Okun | Chief Accounting Officer (Principal Accounting Officer) |
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of PerkinElmer, Inc., hereby severally constitute Prahlad Singh and James M. Mock, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names, in the capacities indicated below, this Annual Report on Form 10-K and any and all amendments to said Annual Report on Form 10-K, and generally to do all such things in our name and behalf in our capacities as officers and directors to enable PerkinElmer, Inc. to comply with the provisions of the Securities Exchange Act of 1934, and all requirements of the Securities and Exchange Commission, hereby rectifying and confirming signed by our said attorneys, and any and all amendments thereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date | |||
| By: | /S/ PRAHLAD SINGH, PhD | President, Chief Executive Officer and Director | February 25, 2020 | ||
| Prahlad Singh, PhD | (Principal Executive Officer) | ||||
| By: | /S/ JAMES M. MOCK | Sr. Vice President and | February 25, 2020 | ||
| James M. Mock | Chief Financial Officer (Principal Financial Officer) | ||||
| By: | /S/ ANDREW OKUN | Vice President and | February 25, 2020 | ||
| Andrew Okun | Chief Accounting Officer (Principal Accounting Officer) | ||||
| By: | /S/ PETER BARRETT | Director | February 25, 2020 | ||
| Peter Barrett | |||||
| By: | /S/ SAMUEL R. CHAPIN | Director | February 25, 2020 | ||
| Samuel R. Chapin | |||||
| By: | /S/ SYLVIE GRÉGOIRE, PharmD | Director | February 25, 2020 | ||
| Sylvie Grégoire, PharmD | |||||
| By: | /S/ ALEXIS P. MICHAS | Director | February 25, 2020 | ||
| Alexis P. Michas | |||||
| By: | /S/ PATRICK J. SULLIVAN | Director | February 25, 2020 | ||
| Patrick J. Sullivan | |||||
| By: | /S/ FRANK WITNEY, PhD | Director | February 26, 2019 | ||
| Frank Witney, PhD | |||||
| By: | /S/ PASCALE WITZ | Director | February 25, 2020 | ||
| Pascale Witz |
Previous: Item 15. Exhibits and Financial Statement Schedules